1. 2758 Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?. (September 2015) Authors: Kolomainen, D.; Butler, J.; Barton, D. P.J.; Taylor, A.; Stanley, K.; Gore, M.; Banerjee, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2763 Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). (September 2015) Authors: Seifert, H.; Georgiou, A.; Alexander, H.; Bodla, S.; Kaye, S.; Nobbenhuis, M.; Gore, M.; Banerjee, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2767 Second line systemic treatment options for recurrent/advanced cervical cancer - The Royal Marsden experience. (September 2015) Authors: Boussios, S.; Glaessgen, D.; Okines, A.; Lalondrelle, S.; Taylor, A.; McLachlan, J.; Gore, M.; Kaye, S.; Banerjee, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 300 Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanoma. Issue 3 (September 2015) Authors: Rasco, D.W.; Middleton, M.R.; Gonzalez, R.; Corrie, P.; Pavlick, A.; Lorigan, P.; Plummer, R.; Gore, M.; Herbert, C.; Agarwala, S.S.; Logan, T.F.; Khleif, S.N.; Papadopoulos, K.P.; Rangachari, L.; Suri, A.; Xu, Q.; Kneissl, M.; Bozón, V.; Olszanski, A.J. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A combined analytical‐experimental investigation of friction in cylinder liner inserts under mixed and boundary regimes of lubrication. (16th January 2017) Authors: Gore, M.; Morris, N.; Rahmani, R.; Rahnejat, H.; King, P. D.; Howell‐Smith, S. Journal: Lubrication science Issue: Volume 29:Number 5(2017) Page Start: 293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Acute renal allograft rejection after immune checkpoint inhibitor therapy for metastatic melanoma. (6th March 2016) Authors: Spain, L.; Higgins, R.; Gopalakrishnan, K.; Turajlic, S.; Gore, M.; Larkin, J. Journal: Annals of oncology Issue: Volume 27:Number 6(2016:Jun.) Page Start: 1135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cervical Spine Fractures in Patients Undergoing Palliative Radiotherapy to the Cervical Spine: Implications for Practice. Issue 7 (July 2018) Authors: Shelley, C.; Gore, M.; Tan, S.; Thomas, K.; Eeles, R. Journal: Clinical oncology Issue: Volume 30:Issue 7(2018) Page Start: 458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation‐positive metastatic melanoma, including recognition and management of rare presentations. (11th October 2015) Authors: Sinha, R.; Larkin, J.; Gore, M.; Fearfield, L. Journal: British journal of dermatology Issue: Volume 173:Number 4(2015:Oct.) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cutaneous toxicities associated with vemurafenib therapy in 107 patients with BRAF V600E mutation‐positive metastatic melanoma, including recognition and management of rare presentations. (1st October 2015) Authors: Sinha, R.; Larkin, J.; Gore, M.; Fearfield, L. Journal: British journal of dermatology Issue: Volume 173:Number 4(2015:Oct.) Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Management of an acute abdomen following high-dose cytosine arabinoside. Issue 739 (May 1987) Authors: Lakhani, A.; Gore, M.; Powles, R. Journal: Postgraduate medical journal Issue: Volume 63:Issue 739(1987) Page Start: 413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗